Remove Clinical Trials Remove Dermatology Remove Genotype Remove Insulin
article thumbnail

Top 7 Pharma Industry Leaders in 2020 By the Numbers

Delveinsight

Apart from these, Xarelto (for PAD) and Darzalex (for Amyloidosis and Refractory Multiple Myeloma) are in Phase III of clinical trials, while Tremfya (for Crohn’s Disease), Seltorexant (for insomnia), and Ciltacabtagene Autoleucei (BCMA CAR-T) (for multiple myeloma) are in Phase II of development. It generated a revenue of USD 14.71